Express Scripts (ESRX) Q4 Earnings Top, Long-Term View Solid
Zacks Investment Research | Feb 27, 2018 08:52PM ET
Express Scripts Holding Company (NASDAQ:ESRX) posted fourth-quarter 2017 adjusted earnings of $2.16 per share, which beat the Zacks Consensus Estimate of $2.08. Further, adjusted earnings improved from $1.88 per share in the year-ago quarter.
Revenues of $25.38 billion also beat the Zacks Consensus Estimate of $25.12 billion and increased from $25.12 billion in the year-ago quarter..
Q4 Patient-Claim Volume Details
Express Scripts’ fourth-quarter 2017 results benefited from a rise in patient claims and strong customer retention.
Adjusted network claims were 270.3 million, up 1.54% year over year.
Adjusted home delivery and specialty claims were 85.5 million in the fourth quarter, down 3.6% year over year.
As a result, net adjusted claims in the fourth quarter were 355.8 million, flat on a year-over-year basis.
Notably, adjusted EBITDA (earnings before interest, tax, depreciation and amortization) per adjusted patient claim in the fourth quarter was $6.04, higher than $5.79 reported in the year-ago quarter.
Express Scripts Holding Company Price and Consensus
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.